Interleukin 12B

Alternative Names

  • IL12B
  • IL12, Subunit p40
  • Interleukin 23, p40 Subunit
  • Cytotoxic Lymphocyte Maturation Factor 2
  • CLMF2
  • Natural Killer Cell Stimulatory Factor, 40-KD Subunit
  • NKSF2

Associated Diseases

Immunodeficiency 29
Back to search Result
OMIM Number

161561

Gene Map Locus
5q33.3

Description

The human Interleukin 12 cytokine is made up of two separate chains, a heavy 40 kDa chain and a lighter 35kDa chain.  The Interleukin 12B gene (IL12B) codes for the heavy p40 chain of the IL12 protein.  IL12 plays a major role in inducing the production of interferon gamma by natural killer cells and T lymphocytes, and thus is an important component of the immune system.  In addition, IL12B can also associate with IL23p19 to form IL23, which in turn is involved in the induction of IL-17 producing T cells. 

Mutations in IL12B gene are implicated in Immunodeficiency 29 (IMD29), a condition characterized by loss of interferon gamma mediated immunity, and susceptibility to mycobacterial infections.  Patients deficient in IL12B are therefore, susceptible to BCG vaccination.  Certain polymorphisms have also been reported to be associated with asthma severity in children as well as in psoriasis.  In addition, over expression of this gene has been observed in the central nervous system of patients with multiple sclerosis (MS), suggesting a role of this cytokine in the pathogenesis of the disease.

Molecular Genetics

The IL12B gene is located on the long arm of chromosome 5, where it spans a length of 16 Kb.  The gene consists of eight exons, the first and last of which are non-coding.  The 40 kDa IL12B protein is made up of 328 amino acids.  It forms a disulfide linked heterodimer with IL12A, giving rise to the functional IL12 cytokine.  It also forms a heterodimer with IL23A to give rise to the functional IL23 protein.

Epidemiology in the Arab World

View Map

Other Reports

Egypt

The frequencies of one IL12B gene polymorphism (rs3212227) in Egyptians were the subject of a study by Youssef et al. (2013).  The study included 238 subjects: 100 healthy controls and 138 patients with HCV infection.  In healthy individuals, genotype frequencies for AA, AC, and CC were 46%, 39%, and 15%, respectively.  No significant difference was observed of the rs3212227 genotypes between controls and patients with HCV infection.  However, the C allele appeared as a predisposing factor for HCV infection in men, whereas it is a protective factor in women.

Saudi Arabia

Picard et al. (2002) described ten patients from four different Saudi kindreds affected with IMD29.  All patients were born to first-cousin consanguineous parents, originating from and living in Saudi Arabia.  Cell lines derived from probands from three of these families were found to secrete neither of the IL12 protein chains.  WBCs from one of these patients were also found to not produce these proteins.  IL12B sequencing revealed the presence of a homozygous insertion mutation-g.315_316insA (315insA)- in all the affected Saudi children in the study.  This mutation was not found in 115 healthy Arabian control subjects.  The frameshift caused by this insertion was predicted to result in a premature termination at nt. 342-344.  The predicted mutant protein lacked all the residues shown by X-ray crystallography to be essential for the dimerization of IL12B with IL12A.  Since the four families were unrelated, the authors used polymorphic markers to genotype common haplotypes shared by the affected patients.  All the affected Saudi patients were found to share a 0.516 Mb common haplotype defined by three intragenic SNPs and two microstaellites, suggesting a founder event.  Using a mutation-dating method, the authors dated the closest common ancestor to 47 generation ago, providing an estimate of ~1,100 years for the founder mutation. 

Prando et al. (2013) extended this study by incorporating 14 Saudi consanguineous kindreds with IL12B deficiency.  These included the four families described by Picard et al. (2002) and an additional 10 kindreds with 17 affected children.  Patients in all families were found to be homozygous for the same insertion mutation (315insA) in the IL12B gene.  Using this larger group too, the date of the founder event was estimated at ~1,000 years ago.

Tunisia

Elloumi-Zghal et al. (2002) described three Tunisian patients with IL12B Deficiency from two different families.  Genotyping and sequencing indentified the same homozygous 8bp deletion in the IL12B gene.  This 297del8 mutation resulted in premature termination of the protein at nt. 342-344.  This mutation could not be detected in 30 control subjects.  Although the two families were unrelated, they originated from the same town in Central Tunisia, suggesting a common ancestor and a founder mutation. 

Prando et al. (2013) extended this study by incorporating six Tunisian kindreds with IL12B deficiency.  These included the two families described by Elloumi-Zghal et al. (2002) and an additional four kindreds with at least five affected children.  Patients in all families were found to be homozygous for the same insertion mutation in the 297del8 IL12B gene.  Later, Ben-Mustapha et al. (2014) studied this mutation in Tunisian patients and estimated that the founder mutation arose ~1,100 years ago. 

© CAGS 2024. All rights reserved.